Table 2 Best tumor response evaluated by mRECIST
mRECIST | Total enrolled Patients (n = 114) | SBRT + LEN group (n = 37) | LEN group (n = 77) | Pa value |
|---|---|---|---|---|
Complete response, n (%) | 4 (3.5%) | 3 (8.1%) | 1 (1.3%) | 0.100 |
Partial response, n (%) | 32 (28.1%) | 18 (46.8%) | 15 (19.5%) | 0.001 |
Stable disease, n (%) | 48 (42.1%) | 13 (35.1%) | 34 (44.2%) | 0.360 |
Progressive disease, n (%) | 30 (26.3%) | 3 (8.1%) | 27 (35.1%) | 0.005 |
ORR, n (%) | 36 (31.6%) | 21 (56.8%) | 16 (20.8%) | 0.000 |
DCR, n (%) | 84 (73.7%) | 34 (91.9%) | 50 (64.9%) | 0.005 |